Back to results
US 2012/0251534 A1Published application
Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
OwnerAntonio J. Grillo-Lopezinventor
Life of this patent
Estimating the term…
Abstract
New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin's lymphomas.
Claims4
A method of treating rituximab-refractory B-cell non-Hodgkin's lymphoma, comprising administering an anti-CD20 antibody to a patient in an amount effective to treat the lymphoma.
Dependencies are inferred from the claim text.